Laboratory Evaluation for Suspected Kidney Stones
Every patient presenting with suspected kidney stones requires immediate biochemical urine work-up (dipstick) and blood tests including creatinine, uric acid, ionized calcium, sodium, potassium, blood cell count, and C-reactive protein (CRP). 1
Emergency/Initial Laboratory Assessment
All patients presenting acutely with suspected urolithiasis need the following baseline tests 1:
- Urine dipstick analysis – screens for hematuria, infection (nitrites, leukocyte esterase), and pH 1
- Serum creatinine – assesses renal function and identifies chronic kidney disease 1
- Ionized calcium – screens for hypercalcemia and primary hyperparathyroidism 1
- Serum uric acid – evaluates for hyperuricemia (though this does NOT predict hyperuricosuria) 2
- Electrolytes (sodium, potassium) – if intervention is planned 1
- Complete blood count – identifies infection or anemia 1
- C-reactive protein – markers of systemic inflammation or infection 1
- Urine culture – mandatory if infection is suspected 1
Critical Caveat on Blood Test Limitations
Serum calcium is the only blood test with proven utility for metabolic screening in kidney stone patients. 2 A 2021 prospective study of 709 patients found that elevated serum calcium detected primary hyperparathyroidism in 4.6% of women and 0.2% of men, but other blood tests provided minimal diagnostic value 2:
- Hyperuricemia does NOT correlate with hyperuricosuria (21.6% had hyperuricosuria regardless of serum uric acid) 2
- Hypophosphatemia does NOT predict hypercalciuria 2
- Serum chloride and bicarbonate failed to identify any cases of distal renal tubular acidosis 2
Additional blood tests beyond serum calcium may provide false reassurance and are not cost-effective for metabolic screening. 2
Stone Analysis
Stone composition analysis should be performed for all first-time stone formers, if not all stone formers. 1 The ideal analytical protocol combines 3:
- Stereoscopic microscopy (StM)
- Scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM-EDS)
- Fourier-transform infrared spectroscopy (FTIR) when necessary
This morpho-compositional analysis reveals nucleation sites, crystal growth patterns, and specific lithogenic processes beyond simple chemical identification. 3
Risk Stratification for Extended Metabolic Evaluation
High-Risk Patients Requiring 24-Hour Urine Collection
Only patients at high risk of stone recurrence should undergo comprehensive metabolic assessment with 24-hour urine collection. 1 This includes measurement of 1, 3:
- Calcium
- Phosphate
- Citrate
- Oxalate
- Uric acid
- Magnesium
- Sodium
- Proteinuria
High-risk criteria warranting 24-hour urine studies 1, 4, 5:
- Recurrent stone formers (≥2 episodes) 1
- Children and adults aged ≤25 years 1
- Bilateral stone disease 1
- Strong family history 1
- Large stones (>20 mm) 5
- Complex medical comorbidities 5
- Solitary kidney 1
- Chronic kidney disease or end-stage kidney disease 1
Genetic Testing Indications
Next-generation sequencing should be considered for 1:
- Children and adults aged ≤25 years (monogenic forms occur in 12–21% of this population) 1
- Adults >25 years with suspected inherited or metabolic disorders 1
- Patients with recurrent stones (≥2 episodes), bilateral disease, or strong family history 1
Genetic testing must be combined with metabolic evaluations, and pre-test counseling is essential. 1 If a genetic diagnosis is confirmed, family screening should be offered. 1
Special Populations
Pregnant Women
For imaging in pregnant women, use ultrasound as first-line, magnetic resonance imaging as second-line, and low-dose CT only as last-line option. 1
Patients with Suspected Infection
Immediate evaluation is indicated in patients with fever, solitary kidney, or diagnostic uncertainty regarding renal colic. 1 These patients require urgent urine culture and blood cultures if sepsis is suspected. 1
Common Pitfalls to Avoid
Do not rely on serum uric acid to predict hyperuricosuria – there is no correlation between serum and urinary uric acid levels 2
Do not skip stone analysis – composition guides targeted prevention strategies and identifies hereditary conditions 1, 3
Do not order extensive blood panels for routine screening – only serum calcium has proven utility for detecting metabolic disorders in stone formers 2
Do not delay 24-hour urine collection in high-risk patients – early metabolic profiling enables targeted prevention and reduces recurrence 1, 4
Beware of false-negative imaging in early presentation – secondary signs of obstruction (hydronephrosis, ureterectasis) may be absent during the first 2 hours after symptom onset 6